Company Protagonist Therapeutics Inc Nasdaq
Equities
US74366E1029
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- PTS | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100.0
%
| 27 | 100.0 % | 60 | 100.0 % | +125.73% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 27 | 100.0 % | 60 | 100.0 % | +125.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 30/11/08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 17/04/22 |
Chief Tech/Sci/R&D Officer | - | 30/06/17 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 23/05/18 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 06/11/22 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 16/01/19 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 31/12/16 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 31/08/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 07/06/17 |
Harold Selick
CHM | Chairman | 69 | 31/01/09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 25/10/23 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 30/11/08 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 11/08/20 |
William Waddill
BRD | Director/Board Member | 67 | 30/06/16 |
Bryan Giraudo
BRD | Director/Board Member | 48 | 15/05/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,652,133 | 56,866,179 ( 96.96 %) | 0 | 96.96 % |
Company contact information
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSector
1st Jan change | Capi. | |
---|---|---|
+52.36% | 58.06B | |
-3.86% | 40.53B | |
+36.75% | 38.99B | |
-12.01% | 26.56B | |
+14.13% | 26.7B | |
-21.62% | 18.98B | |
+0.21% | 12.17B | |
+25.96% | 11.92B | |
+23.02% | 12B |
- Stock Market
- Equities
- PTGX Stock
- Stock
- Company Protagonist Therapeutics Inc